Gts Securities »

Akero Therapeutics shares owned by Gts Securities

Quarter-by-quarter ownership of Akero Therapeutics (AKRO) shares owned by Gts Securities from 13F filings

Historical chart of Gts Securities investment in Akero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akero Therapeutics held by Gts Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akero Therapeutics by Gts Securities

Quarter filed Position value Share count Share price at filing
2023-12-31 $283k 12k 23.35
2023-09-30 $5.7M 114k 50.58

More positions owned by Gts Securities

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
NVIDIA Corporation Put Option (NVDA)
Microsoft Corporation Put Option (MSFT)
Meta Platforms Cl A Put Option (META)
Tesla Motors Put Option (TSLA)
Amazon Put Option (AMZN)
Netflix Put Option (NFLX)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Apple Put Option (AAPL)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Alphabet Cap Stk Cl C Put Option (GOOG)
Advanced Micro Devices Put Option (AMD)
Broadcom Put Option (AVGO)
Costco Wholesale Corporation Put Option (COST)

View all positions for Gts Securities

Top funds holding Akero Therapeutics

Henderson Group
T. Rowe Price Associates
Vanguard Group
Wellington Management Company
Baker Bros. Advisors
Yiheng Capital
Boxer Capital
Alliancebernstein
Redmile Group
Perceptive Advisors
Logos Global Management
Point72 Asset Management
Citadel Advisors
Goldman Sachs Group
Holocene Advisors

View all funds holding Akero Therapeutics